Pulmonary Arterial Hypertension Market Size By Drug Class (Prostacyclin And Prostacyclin Analogs, Soluble Guanylate Cyclase (SGC) Stimulators, Endothelin Receptor Antagonist (ERA), Phosphodiesterase 5 (PDE-5), Vasodilators), By Route of Administration (Oral, Intravenous, Inhalation), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Your personal details will remain secure and confidential - Privacy Policy

Premium Report: Details

  • Published Date: Aug 2021
  • Pages: 120
  • Tables: 130
  • Charts / Figures: 13
  • Companies covered: 7
  • Countries covered: 18

Buy Now

Single User: $5,150 Access to only 1 person; cannot be shared
Multi User: $7,150 Access for 2 to 5 users only within same department of one company
Enterprise User: $9,150 Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X